Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Non-steroidal anti-inflammatory drugs Stories

2011-01-05 00:00:39

Cur-OST®- all natural anti-inflammatory supplement which helps to reduce pain, improves quality of life and reduces dependence on prescription pain medications in horses and dogs afflicted with arthritis, laminitis and other inflammatory conditions. Cur-OST® is clinically proven and research supported. Jonesville, NC (PRWEB) January 4, 2011 Arthritis in horses and dogs is a debilitating condition resulting in tremendous suffering, pain and loss of function. Nouvelle Veterinary...

2010-12-08 13:20:17

Use of low-dose aspirin prior to a newer type of fecal occult blood test is associated with a higher sensitivity for detecting advanced colorectal tumors, compared to no aspirin use, according to a study in the December 8 issue of JAMA. "Screening for colorectal cancer (CRC) and its precursors by fecal occult blood tests (FOBTs), which has been shown to reduce CRC incidence and mortality in randomized trials, is widely recommended and applied in an increasing number of countries. Screening is...

2010-12-08 08:29:15

(Ivanhoe Newswire) -- Aspirin has proven to do more than just relieve pain, fever, inflammation and strokes. A study from the German Cancer Research Center found that use of low-dose aspirin is associated with a higher sensitivity for detecting advanced colorectal tumors, compared with no aspirin use. Hermann Brenner, M.D., M.P.H., of the German Cancer Research Center, Heidelberg, Germany, and colleagues assessed the association of use of low-dose aspirin with performance of 2 immunochemical...

ee9245ed0bc627c799e48735a49a52f1
2010-12-07 08:25:00

Researchers at Oxford University and other British institutes have found that taking low-dose aspirin on a daily basis can help reduce the risk of cancer by 20 percent. "Daily aspirin reduced deaths due to several common cancers during and after the trials," the researchers wrote in The Lancet on Tuesday. "Benefit increased with duration of treatment and was consistent across the different study populations. These findings have implications for guidelines on use of aspirin and for...

39782fde37d4d1e3ecbd054cb5cd2e34
2010-12-03 13:44:29

Swiss researchers have tied asthma risks to several common painkillers, adding more controversy about the role of such drugs around the world. However, the team said their work hints that painkillers are not at the root of the problem, but rather a consequence of it. Earlier studies found that kids who commonly take acetaminophen are more likely to develop wheezing and other symptoms of asthma. But it is not understood whether acetaminophen triggers asthma directly or is simply used more...

2010-12-01 08:18:22

(Ivanhoe Newswire) -- Nonmelanoma skin cancers are some of the most commonly diagnosed in the U.S. A new study found a possible preventative treatment in the nonsteroidal, anti-inflammatory drug Celecoxib. Celecoxib is typically used to inhibit the enzyme cyclooxygenase 2, which has been associated with the onset of UV ray-caused nonmelanoma skin cancers.  Since sunscreen has only shown mediocre results in protecting reducing these cancers, researchers at the University of Alabama at...

2010-11-30 21:58:02

New research shows the NSAID Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have pre-cancerous actinic keratoses lesions and are at high risk for having the disease. The researchers, led by University of Alabama at Birmingham senior scientist and the study's lead author, Craig Elmets, M.D., co-leader of the UAB Comprehensive Cancer Center 's Chemoprevention Program, evaluated the efficacy and safety of celecoxib as a chemo-preventive agent for actinic...

2010-11-18 08:02:00

WASHINGTON, Nov. 18, 2010 /PRNewswire/ -- Comedienne, television host, author and mother Joy Behar, and her daughter Eve, will be honored at AARP The Magazine's 2011 Inspire Awards gala on December 9 in Washington, D.C. for a public awareness campaign aimed at urging women -- who are less likely than men to survive a heart attack(i) -- to be prepared if heart attack strikes without warning. AARP The Magazine's Inspire Awards recognize people who have inspired others to action through...

2010-11-17 06:30:00

IRVINE, Calif., Nov. 17, 2010 /PRNewswire/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced the U.S. Food and Drug Administration (FDA) has granted the Company three years of marketing exclusivity for BROMDAY(TM) (bromfenac ophthalmic solution) 0.09%, as provided under the Drug Price Competition and Patent Term Restoration Act, commonly known as the Hatch-Waxman Act. BROMDAY (formerly referred to as XiDay), the first and only once-daily prescription eye drop for the treatment...

2010-11-16 07:30:00

BEDMINSTER, N.J., and MILTON, Canada, Nov. 16, 2010 /PRNewswire/ -- Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company, and Tribute Pharmaceuticals, a privately-held Canadian specialty pharmaceutical company, announced today their exclusive license agreement for the commercialization of CAMBIA(TM) (diclofenac potassium for oral solution) in Canada. CAMBIA(TM) is approved in the United States for the acute treatment of migraine with or without aura and was...